Methylprednisolone and Cyclophosphamide for lung fibrosis Information for patients

Similar documents
This leaflet can be made available in other formats including large print, CD and Braille and in languages other than English, upon request.

Pressure Ulcer Prevention

Methicillin Resistant Staphylococcus aureus (MRSA) screening and decolonisation

Loop excision treatment Gynaecology Outpatient Department

This leaflet can be made available in other formats including large print, CD and Braille and in languages other than English, upon request.

Implantable Loop Recorder (ILR)

Cardiac Investigations

This leaflet can be made available in other formats including large print, CD and Braille and in languages other than English, upon request.

When someone is dying Information for Relatives and Carers

Upper gastro-intestinal (GI) endoscopy

Laparoscopic Nissen Fundoplication

Coronary angiogram - Outpatients

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FMD. Patient s first names.

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Cyclophosphamide INFUSION Infusion 4 Plus

Patient information. Breast Reconstruction TRAM Breast Services Directorate PIF 102 V5

Laparoscopic Gastric Bypass

Infliximab Infusion for Patients with Ulcerative Colitis Patient Information Leaflet

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Infliximab Infusion for Patients with Crohns Disease Patient Information Leaflet

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Abbvie 3D for the treatment of Hepatitis C Genotype 1

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION

Harvoni for the treatment of Hepatitis C

Laparoscopic Radical Nephrectomy

Treatment of non-muscle invasive bladder cancer with BCG and EMDA MMC

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

What is TB? Prevention is better than cure. You can get latent or active TB even if you have had a BCG vaccination

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients

National Hospital for Neurology and Neurosurgery. About plasma exchange Plasma Exchange Service

Having a Vena Cava Filter

Partial glossectomy. Your operation explained. Information for patients Head and Neck Centre

Enhanced recovery after laparoscopic surgery (ERALS) programme. Patient information and advice

Urology Enhanced Recovery Programme: Laparoscopic/open simple/radical/partial/donor nephrectomy. Information For Patients

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 + RITUXIMAB

The Clatterbridge Cancer Centre. NHS Foundation Trust MRSA. Infection Control. A guide for patients and visitors

Children s Ward Parent/Carer Information Leaflet

Patient Diary. Enhanced Recovery After Surgery (ERAS) Total Knee Replacement. Helping patients get better sooner after surgery.

Welcome to OPEN DOORS

A Total Colectomy is the surgical removal of the entire colon (last part of the intestine/gut). It does not involve the removal of the rectum.

University College London Hospitals (UCLH) Preventing venous thromboembolism (VTE)

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Having an operation as a day patient (under a general or local anaesthetic)

Coordinating Access to Obtain ZOLINZA

Welcome to the Peter Moorhead Dialysis Unit. Information for patients Sheffield Kidney Institute (Renal Unit)

Radical cystectomy enhanced recovery plan. Information for patients

Preventing hospital-acquired blood clots

Insertion of a PICC (Peripherally Inserted Central Catheter) / Mid Line

Participant Information Sheet Main Trial. ATAFUTI A Trial Investigating Alternative Treatments for Adult Female Urinary Tract Infection

Getting Started on. (iloprost) Inhalation Solution VENTAVIS

Endometrial Cancer. Information for patients. Gynaecology Department. Feedback

Having a blue light cystoscopy

Percutaneous nephrolithotomy (PCNL)

Excision of Submandibular Gland

Hickman line insertion in the interventional radiology department

Left Hemicolectomy Patient Information

The Leeds Teaching Hospitals NHS Trust Transplant Patients Discharge training

The Gynaecology Ward, The Women s Centre. Minor Surgery. Your nursing care, recovery, and getting back to normal

Insertion of a ventriculo-peritoneal or ventriculo-atrial shunt

Chemotherapy services at the Cancer Centre at Guy s

Surgical Treatment for Cancer of the Oesophagus

INFORMATION FOR PATIENTS WHO ARE PREPARING FOR LUNG RESECTION SURGERY

The Children s Hospital Children s Day Care Ward, Tom s Ward. Labial Adhesions. Information for parents and carers

Nephrectomy (kidney removal): information and advice for patients on the enhanced recovery programme

Oral Ibrutinib (single agent)

Pancreaticoduodenectomy enhanced recovery programme (PD ERP) Information for patients

Arthroscopic Decompression Surgery

PATIENT AGREEMENT TO SYSTEMIC THERAPY: GENERIC CONSENT FORM. Patient s first names. Date of birth. Job title

Abdomino-perineal Resection/Excision of the Rectum

You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath

Having an endoscopic retrograde cholangio-pancreatograph (ERCP)

INFORMATION FOR PATIENTS

Blood clot prevention. A guide for patients and carers

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names

Northumbria Healthcare NHS Foundation Trust. CT (Computerised Tomography) Issued by Radiology Department

Etoposide (VePesid ) ( e-toe-poe-side )

Enhanced Recovery Programme for Nephrectomy (Kidney Removal)

Laparoscopic partial nephrectomy

Enhanced recovery after oesophagogastric surgery (EROS) Patient information and advice

Viral gastroenteritis (norovirus)

What you can do to help stop the spread of MRSA and other infections

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.

Guidance on the Enhanced Recovery Programme in Colorectal Surgery Surgery Patient Information Leaflet

Participant Information Sheet Adults

Right Hemicolectomy Patient Information

Discharge Advice Following Breast Reconstructive Surgery

Welcome to our latest Newsletter

The operation will take several hours and you will stay in the recovery room until you are ready to return to the ward.

Patient information. Axillary Node Surgery (Operations on the Armpit) Breast Directorate PIF 1370 V3

Meet the Pharmacy Team Experts in Medicine. Pharmacy Department

Enhanced Recovery Programme Major gynaecology surgery

TALK. Health. The right dose. May is Mental Health Month. 4 tips for people who use antidepressants

Having a Day Case TRUS Biopsy (General Anaesthetic) Department of Urology Information for patients

Transcription:

Methylprednisolone and Cyclophosphamide for lung fibrosis Information for patients This leaflet can be made available in other formats including large print, CD and Braille and in languages other than English, upon request.

This information leaflet is for those patients who will undergo treatment with cyclophosphamide and methylprednisolone. What are methylprednisolone and cyclophosphamide? Cyclophosphamide and methylprednisolone are powerful medicines which are used to suppress the immune system. Why have I been prescribed this treatment? You have a lung condition known as pulmonary or lung fibrosis. This may progress or worsen over time due to your immune system being overactive. You have been offered this treatment to try and slow or stop the condition from worsening. Your doctor will have discussed this treatment with other specialists at a meeting to ensure there is agreement that this is the best treatment for you. It is important to realise that this treatment will not reverse or heal the scarring which has already occurred but will hopefully prevent it worsening. What will happen before I start this treatment? Before starting this treatment your doctor will check: That your kidney and liver function are normal, this is done by a simple blood test Whether you have had any recent infections Whether you are prone to bladder infections That you don t have any allergies which may stop this treatment That you aren t pregnant or planning to become pregnant or are breast feeding Whether you have had any vaccinations recently

Whether you have had chicken pox or measles in the past. What will happen during my treatment? The treatment is given in the chemotherapy day unit of either North Tees Hospital or Hartlepool Hospital, whichever is closer to your home. The medication is given in this unit as the staff have the expertise in administering this treatment. Each treatment is called a pulse and these are usually given every 3 4 weeks. The complete treatment will take 4-6 hours. The nurse looking after you will monitor your pulse and blood pressure during the treatment. One hour before each treatment, you will be given a medication to prevent bladder inflammation called Mesna. The 2 medicines are given separately into your vein through a drip and each one takes an hour to be given. After this you will go home. What side effects could I have from this treatment? Every patient is an individual; your experience may be different to other patients receiving this treatment. Side effects that you may experience are: - Fatigue - Many people feel tired and have low energy levels for a few days after treatment. If you suffer fatigue it is best to take gentle exercise and rest often. This feeling of fatigue is quite normal and energy levels should begin to improve a few days after treatment. Nausea (feeling sick) and vomiting (being sick) - The severity of any nausea and vomiting will vary from person to person. To try and stop this you will be given an anti-sickness drug before receiving your treatment and some tablets to take home with you.

An increased risk of infection You may be more prone to catching infections when receiving this treatment. If possible, it is best to avoid contact with people who have nasty colds, whilst you are receiving this treatment. It is also best to avoid contact with children who have chicken pox. If you have contact with a child who develops chicken pox, please contact your consultant or GP, so that we can check if you are immune to chicken pox. This is done by performing a blood test at the hospital. Rarely a patient may develop a very severe lung infection called PCP or pneumocystis whilst on this treatment. We try to prevent this infection by asking you to take an antibiotic called cotrimoxazole (Septrin) while you are receiving this treatment. You will receive information about symptoms to look out for and who to contact if you are feeling unwell from the nurses at the chemotherapy day unit. Inflammation of the bladder This may occur with the treatment. To help prevent this, you will be given additional fluid by a drip asked to drink plenty of fluids for 24 hours after the treatment. We suggest that you drink approximately 3 litres of fluid on the day of your infusion. Infertility - If you are planning to have a family in the future please tell your doctor as cyclophosphamide can make some people infertile. Infertility may be permanent and can occur in both men and women. For men wishing to father children in the future, you will need to consider sperm banking prior to treatment. In women, cyclophosphamide may also cause a temporary or permanent change in monthly periods, causing them to become irregular or causing them to stop. Women may experience an earlier menopause.

Other possible side effects Very rarely some patients experience hair thinning which will grow back on completion of the treatment. You also may experience mouth ulcers and thrush. Will I need more tests while I am taking this treatment? You will need a blood test before each pulse. This will be performed in the chemotherapy day unit 5-7 days before the next treatment. We will test your urine before every treatment to ensure that you are not developing an infection or any bladder inflammation. What if I miss a pulse of this treatment? If you need to miss a pulse for any reason then inform the chemotherapy day unit staff and they will arrange another date. If you are missing a pulse due to side effects they will discuss with your consultant who will decide on further treatment. Can this treatment react with my other tablets? Cyclophosphamide can react with some other medications. Your consultant will review all of your medication to ensure that there aren t any potential problems. It is important that you also tell your consultant of any herbal or over the counter medications you are taking in addition. Can this treatment affect pregnancy or breastfeeding? Yes. Cyclophosphamide must not be taken during pregnancy or breastfeeding as it can harm a developing baby and also pass to your child in breast milk.

Both men and women should avoid starting a family for at least 6 months after treatment. It is important that you continue to use highly reliable contraception while you are having treatment. Please inform your consultant or nurse if your period is late and you think you may be pregnant. Should this treatment be stopped for an operation? Yes. If you need to undergo any elective operations you must tell the team looking after you as they will need to decide how long to stop the treatment for before you can undergo an operation. Can I drink alcohol while taking this treatment? Yes, but please drink alcohol in moderation. You should not receive this treatment whilst you have an infection. Please let your nurse or doctor know if you develop any infections. Contact Numbers University Hospital of North Tees Chemotherapy day Unit Telephone: 01642 383122 Lung Health Telephone: 01642 624270 Department of Respiratory Medicine Telephone: 01642 624936

Emergency Department Telephone: 01642 382899 24 hours a day, 7 days a week University Hospital of Hartlepool Chemotherapy Day Unit Telephone: 01429 622760 Further information is available from: NHS Choices Telephone: 111 (when it is less urgent than 999) Calls to this number are free from landlines and mobile phones. or via the website at www.nhs.uk Telephone: 01642 382899

This leaflet has been produced in partnership with patients and carers. All patient leaflets are regularly reviewed, and any suggestions you have as to how it may be improved are extremely valuable. Please write to the Quality Assurance Team, University Hospital of North Tees or email: patientinformation@nth.nhs.uk Comments, Concerns, Compliments or Complaints We are continually trying to improve the services we provide. We want to know what we re doing well or if there s anything which we can improve, that s why the Patient Experience Team is here to help. Our Patient Experience Team is here to try to resolve your concerns as quickly as possible. If you would like to contact or request a copy of our PET leaflet, please contact: telephone: 01642 624719 Monday Friday, 9.00am 4.00pm Messages can be left on the answering machine and will be picked up throughout the day. freephone: 0800 092 0084 Email: patientexperience@nth.nhs.uk Out of hours if you wish to speak to a senior member of Trust staff, please contact the hospital switchboard who will bleep the appropriate person. telephone: 01642 617617 24 hours a day, 7 days a week The Patient Experience Team is available to discuss your concerns in person Monday Friday, 1.30pm 4.30pm. The office is based on the ground floor at the University Hospital of North Tees. Data Protection and use of patient information The Trust has developed a Data Protection Policy in accordance with the Data Protection Act 1988 and the Freedom of Information Act 2000. All of our staff respect this policy and confidentiality is adhered to at all times. If you require further information please contact the Information Governance Team. telephone: 01642 833551 or email: information.governance@nth.nhs.uk University Hospital of North Tees, Hardwick, Stockton-on-Tees. TS19 8PE University Hospital of Hartlepool, Holdforth Road, Hartlepool. TS24 9AH Telephone: 01642 617617 Fax: 01642 624089 PIL1023 February 2018